| Logo | Name | Σ | Employees | ||
|---|---|---|---|---|---|
 |  Kernal Biologics KernalBio creates mRNA therapies that instruct specific cells on how to make their own medicine Kernal creates mRNA therapies to cure severe diseases including cancer. Our mRNA therapies instruct specific cells on how to make their own drugs. With roots at MIT, Harvard and Big Pharma, our team previously built a successful Biotech company and has deep expertise in mRNA space. synthetic biology, RNA design, immunotherapy, covid-19, cancer, and mRNA therapy Type: | 10 | 2 | 4 | 16 |
 | Poolbeg Pharma plc Committed to the development and commercialisation of innovative medicines. Ticker: POLB Poolbeg Pharma plc is committed to the development and commercialisation of innovative medicines targeting diseases with a high unmet medical need, with a growing emphasis on rare and orphan diseases. Its model focusses upon developing its exciting clinical assets and commercialising approved and marketed drugs to fund the development of its robust pipeline of innovative products, thereby driving significant value creation. Poolbeg is led by an experienced leadership team with a history of delivering significant shareholder value. The team has been strengthened by the appointment of three former members … Type: | 6 | 0 | 6 | 15 |
 |  Pharvaris Pioneering science for patient choice Pharvaris is a clinical-stage company focused on bringing oral bradykinin-B2-receptor antagonists to patients. By targeting this clinically proven therapeutic target with novel small molecules, the Pharvaris team is advancing new alternatives to injected therapies for all sub-types of HAE and other bradykinin-mediated diseases. The company brings together executives with a breadth of expertise across pharmaceutical development and rare disorders, including HAE. The company reunites the core team responsible for the discovery and approval of the HAE treatment icatibant. With novel small molecules, we have identified and are advancing potent, orally available compounds targeting this clinically … Type: | 0 | 0 | 0 | 113 |
 | Tagworks Pharmaceuticals Pioneer of Click-to-Release chemistry; designing more effective and safer systemic therapies Tagworks Pharmaceuticals is a precision oncology company using our proprietary Click-to-Release treatment platform to develop a new standard of care for patients suffering from solid tumors by targeting clinically validated tumor markers that so far have remained out of reach of current therapies. Our lead program, TGW101, is an antibody-drug conjugate (ADC) targeting TAG72, a non-internalizing protein found on the surface of many solid tumor cells. We are developing a pipeline of novel cancer treatments leveraging our Click-to-Release technology in a range of therapeutic modalities, including ADCs and targeted … Type: | 1 | 0 | 0 | 28 |
 | Dicot Pharma AB Dicot is a pharmaceutical company focused on increasing well-being through innovations that enhance sexual health. Dicot is a pharmaceutical company focused on increasing quality of life and well-being through innovations that enhance sexual health. The company develops and manufactures medicines for the treatment of erectile dysfunction and premature ejaculation. The company's lead candidate, LIB-01, is in clinical stage of development. erectile dysfunction, biopharma, premature ejaculation, drug development, pharma, sexual health, lifestyle , drug discovery, lifestyle, drug discovery, drugs from nature, and biopharmaceutical Type: | 0 | 0 | 0 | 7 |
 | haelsi [Automatic translation follows] Putting your team's health first 💛 Gain health, time and talent for your team With the most modern health benefit in Austria, your employees will be healthier and more productive, and your employer branding more attractive. We make health easy. For you and your team: 💛 Healthy, productive teams: A single point of contact for all your employees' health questions. 💛 Fewer absences due to illness: Fast, punctual appointments, convenient online offers and annual preventive check-ups included. 💛 Better recruiting and employee retention: 80% of all employees want health benefits from their employer. 💛 Tax-free benefit with … Type: | 2 | 1 | 2 | 35 |
 | Algorithmiq We develop advanced quantum algorithms to solve complex problems in life sciences Algorithmiq is a company developing advanced algorithms to solve complex problems in life sciences. Our mission is to revolutionise life sciences by exploiting the potential of quantum computing to solve currently inaccessible problems. We combine our expertise in quantum information, complex systems, and computational physics to develop algorithms that run on near-term quantum devices to discover new drugs and develop new materials Quantum physics, Complex networks, Quantum computing, Quantum simulations, Quantum chemistry, Quantum software, and Computational physics Type: | 13 | 0 | 13 | 40 |
 | PCI Synthesis PCI Synthesis is a company based out of NEWBURYPORT, MA, United States. Type: | 2 | 0 | 2 | 4 |
 | BLUU Seafood REAL SEAFOOD. ZERO TRADE-OFFS. The European pioneer in cultivated seafood. Real fish made from cells – healthier, tastier, more sustainable. Type: | 9 | 5 | 4 | 62 |
 | Atomic AI Rational design of new molecules and medicines, enabled by the fusion of artificial intelligence and structural biology. Atomic AI is a well-funded, early-stage biotech company transforming the rational design of molecules and medicines through the cutting-edge fusion of artificial intelligence and structural biology. Atomic’s unique R&D platform, based on research featured on the cover of Science (doi.org/10.1126/science.abe5650), provides new strategies to treat or cure previously-undruggable diseases by targeting RNA structure. We are an interdisciplinary team working across computational and experimental biology and believe that our strongest asset is our people. We're hiring! https://boards.greenhouse.io/atomai Type: | 2 | 0 | 1 | 34 |
 | JURA Bio, Inc. Building the future of cell-based therapies. CAR-T is for more than just oncology. Using the full potential of gene editing, we are creating a therapeutic platform for cell based therapies that are not just disease modifying: they are curative and definitive. Cell-based Therapies and Machine Learning Type: | 0 | 0 | 0 | 18 |
 | Redesign Science Biology Simulated Founded in 2017, Redesign Science is a platform biotech working at the interface of physics-based molecular simulation and deep learning to create generative AI for drug discovery. We deploy our platform technology to develop first-in-class Protein Interaction Modulators against validated targets known to drive progression of multiple oncogenic and inflammatory diseases. Type: | 0 | 0 | 0 | 11 |
 | A-Alpha Bio The protein-protein interaction company A-Alpha Bio is a biotechnology company harnessing synthetic biology and machine learning to measure, predict, and engineer protein-protein interactions. Our experimental platform, AlphaSeq, enables the rapid and quantitative measurement of millions of protein-protein binding affinities simultaneously. Our computational platform, AlphaBind, is trained on the world’s largest protein-protein interaction database and predicts binding strength from sequence. A-Alpha Bio leverages AlphaSeq and AlphaBind for in-house therapeutic programs and in partnership with leading pharmaceutical companies to inform the discovery and development of novel therapeutics. A-Alpha Bio is based in Seattle and was founded in 2017 at the University of … Type: | 5 | 0 | 5 | 59 |
 | Basecamp Research Beyond Known Biology Basecamp Research is a market leader in mapping biodiversity for AI-based design of biological systems. We match and refine novel proteins for our partners' exact industrial, therapeutic or diagnostic applications using BaseGraphTM, a new generation of AI design that is powered by the first-ever high-resolution map of global genetic biodiversity. Understanding the full genetic, evolutionary, and environmental context of each protein allows Basecamp Research to design tailored proteins for specific applications without the need for expensive and time-consuming directed evolution campaigns. We're a team of explorers, scientists and policy experts driven by our ambition to protect and … Type: | 12 | 1 | 10 | 36 |
 | Ordaos Bio Ordaōs creates de novo mini-proteins to help drug hunters deliver life-saving treatments. Ordaōs is a human-enabled, machine-driven drug design company. Our miniPROTM proteins help drug hunters deliver treatments that are safer and more effective than traditional discovery methods. Type: | 1 | 0 | 1 | 29 |
 | Profluent Decoding the language of life with AI Profluent is an AI-first protein design company. Founded in 2022, we develop deep generative models to design and validate novel, functional proteins to revolutionize biomedicine. Based in Berkeley, CA, we are backed by leading investors including Spark Capital, Insight Partners, Air Street Capital, AIX Ventures, and Convergent Ventures. To learn more about our mission to decode the language of life with AI, visit profluent.bio. artificial intelligence, machine learning, biotech, and gene editing Type: | 1 | 0 | 1 | 38 |
 |  Syntegra Democratizing healthcare data to dramatically accelerate how treatments reach patients. Syntegra is unlocking the promise of real-world evidence by employing a groundbreaking machine learning model — the Syntegra Medical Mind — to enable low-burden access to privacy-preserved and equitable synthetic health data, increasing the value of data for those who have it and providing access for those who need it. Synthetic data matches the statistical accuracy of the underlying data without linking to any actual patients, fully protecting patient privacy. Syntegra’s ever-growing model is built from the statistical patterns of structured healthcare data to serve the diverse needs of our … Type: | 1 | 1 | 0 | 7 |
 | Berkeley Lights Berkeley Lights is now part of Bruker Cellular Analysis Berkeley Lights is now part of Bruker Cellular Analysis biotech, single cell, micro-fluidics, cancer genomics, human oncology, life science, optics, molecular biology, and oncology Type: | 12 | 1 | 9 | 43 |
 | HiFiBiO Therapeutics HiFiBiO Therapeutics is a clinical stage biotherapeutics company mobilizing the human immune system to combat disease. HiFiBiO Therapeutics is a clinical-stage global biotech pioneering a unique high-resolution translational solution (DIS®, Drug Intelligence Science) to enhance the probability of success for immunotherapies. DIS® combines unique single-cell capabilities with AI/ML approaches using patient samples to discover novel targets, effective antibody drugs, and predictive biomarkers. With DIS®, HiFiBiO gains an unprecedented understanding of immune modulation in human diseases driving a robust clinical pipeline of transformative immunotherapies. Additionally, HiFiBiO has partnered with major multinational pharmaceutical and biotech companies applying its innovative DIS® approach. HiFiBiO … Type: | 4 | 1 | 2 | 73 |
 | Cardiac Insight, Inc. The Future of ECG Starts with US. Cardiac Insight, Inc. is a privately held medical device company based in Seattle, Washington, renowned for its Cardea SOLO ECG system. With FDA clearance since 2017, this tool provides comprehensive cardiac evaluations, comfortably worn over seven days. Dr. Dave Hadley and Dr. Vic Frolicher, creators of the Cardea 20/20 ECG, introduced a proprietary handheld 12-lead ECG device that enhances electrocardiogram reliability for detecting cardiovascular issues in young athletes, transforming athletic heart care. The Cardea 20/20 ECG incorporates breakthrough interpretive algorithms and international criteria, enabling swift identification of complex cardiac abnormalities leading to Sudden … Type: | 2 | 0 | 0 | 43 |
 | CMD MedTech Experts in Medical Device Systems Engineering, Project Management, Regulatory and Quality, and Design and Development We're a team of medical device development experts, leveraging decades of medical device and combination product experience to provide your organization with medical device consulting services that meet the expectations of FDA and other regulatory bodies. CMD's mission and vision focus on improving the lives of patients and caregivers around the world. We accomplish this by implementing practical solutions that are "right sized" and focused on getting safe and effective products to market (and keeping them there)! Medical Device Design & Development, Systems Engineering, Project … Type: | 0 | 0 | 0 | 13 |
 | MedTech Launch Evolving MedTech Design and Engineering for Launch Success MedTech Launch by Genesis Plastics Welding, a leading source for excellence in medical device design and engineering services, is powering innovation and evolving Go-To-Market strategies for clients worldwide through a proven and collaborative design, development and pre-production product launch process that strategically takes OEMs, start-ups, innovators and entrepreneurs from initial concept to commercialization all with the human factor and user experience in mind. If you have a product concept you’d like to discuss, or you’d like to learn more about strategic guidance to overcome design hurdles, visit www.medtechlaunch.com. Product Development, Project Management, … Type: | 1 | 0 | 1 | 15 |
 | Locus Biosciences, Inc. Locus Biosciences, Inc. is a biotechnology company that develops precision, engineered bacteriophage products. Locus Biosciences is a clinical-stage biotechnology company developing engineered bacteriophage products to address critical unmet medical needs in bacterial infections and immunology. The LOCUS platform combines predictive artificial intelligence and automated robotics to deliver optimized precision phage therapies that specifically kill target pathogens while leaving non-target bacteria (i.e., the rest of the patient’s microbiome) unaffected. Locus has strong backing from partners, having signed contracts with BARDA and CARB-X. The company recently completed the open-label portion of a Phase 2 trial assessing LBP-EC01 for the treatment of uncomplicated … Type: | 8 | 4 | 4 | 61 |
 | Algonist Biotechnologies Targeting Chronic Pain Algonist Biotechnologies is a pre-clinical stage biotechnology company, developing novel small molecule therapeutics for chronic pain. Our mission is to develop drugs with similar potency to opioids but without leading to addiction. Type: | 0 | 0 | 0 | 3 |
 | Myllia Biotechnology Single-cell CRISPR screening - a powerful approach to fast-forward target identification and drug discovery Myllia Biotechnology combines CRISPR screening with single-cell RNA sequencing, leveraging two transformative technologies to enable genetic screening for complex phenotypes. We utilize the CRISPR screening workflow to map the impact of thousands of genetic perturbations on the global transcriptome at single-cell resolution, thus effectively establishing a paradigm for next-generation CRISPR screens. Our powerful approach has broad applications in identifying novel drug targets or elucidating unknown mechanisms of actions (MoA) of drugs. Each screening project is customized to the specific needs of our clients and we perturb … Type: | 0 | 0 | 0 | 24 |
 | Calyxha Biotechnologies A new perspective on inflammation Calyxha is a private biotech company developing novel small molecule anti-inflammatory drugs. Drug discovery and development Type: | 1 | 0 | 1 | 2 |
 | Regenosca SA Meshes for soft tissue repair Our technology platform TissueSpan creates regenerative and off-the shelf meshes for soft tissue repair. Proof-of-concept is validated in an ongoing First-in-Human study where Regenosca's implants were successfully used to repair a narrowing of the urinary passage, a so called urethral stricture. Thanks to the mesh, tissue healing was induced at the implantation site! The current gold standard for urethral stricture repair is the use of patient's own inner mouth tissue. This second operation site creates additional pain, increases the risk of complications, and prolongates the overall surgery time. No surgeon should be obliged in the … Type: | 0 | 0 | 0 | 3 |
 | Lario Therapeutics Fighting neurological disorders with precision medicine. Type: | 0 | 0 | 0 | 4 |
 | SamanTree Medical SA Bringing the unseen into focus for a cancer-free tomorrow SamanTree Medical proposes a breakthrough innovation for checking complete tumor removal during surgery: the Histolog® Scanner. This novel imaging modality is a direct support during cancer surgery to achieve the common goal of improving patient quality of life by decreasing rates of re-operation. The team is fully dedicated to bringing the Gold Standard in the operating room, enabling margin assessment, in real time, at the histological detail. SamanTree Medical SA was founded in December 2014 and is a spin-off of the EPFL (Ecole Polytechnique Fédérale de Lausanne). linktr.ee/SamanTree microscopy and digital … Type: | 3 | 2 | 1 | 32 |
 | HepaRegeniX GmbH Unlocking liver regeneration - delivering recovery HepaRegeniX GmbH is a clinical-stage biotechnology company developing novel therapies for the treatment of acute and chronic liver diseases. Type: | 1 | 0 | 1 | 12 |
 | SmartCella Holding AB A global biotech company pioneering the future of targeted medicine SmartCella, founded in 2014, is an innovative biotechnology company based in Stockholm, Sweden. SmartCella’s vision is to combine first-in-class delivery platforms with cutting-edge cell and gene therapies to unleash the full potential of targeted therapies. The company has three main business units, Smartwise, SmartCella Solutions and Procella. Smartwise is developing and manufacturing a first-in-class endovascular delivery device, the Extroducer, that enables direct tissue/organ infusions through the vessel wall directly into to hard-to-reach organs and tumors. There is a significant unmet need in the field of targeted delivery of different types … Type: | 0 | 0 | 0 | 62 |
 | Vanarix We developed a new generation of cell therapy products to regenerate articular cartilage damage: Cartibeads Vanarix has developed a new generation of cell therapy to produce high-quality hyaline cartilage mini-grafts, named Cartibeads, which resemble native tissue. Cartibeads are bio-engineered from allogeneic chondrocytes and release their own hyaline matrix. When implanted during minimally invasive arthroscopic surgery, Cartibeads can completely self-integrate into cartilage lesions and thus regenerate the tissue. Cartibeads are designed for the treatment of cartilage defects in traumatic and osteoarthritic joints. Type: | 0 | 0 | 0 | 6 |
 | Orlance Inc Delivering powdered, needle-free vaccines Orlance Inc is a company based out of Seattle, United States. Type: | 0 | 0 | 0 | 7 |
 | Quantum Innovations .we create Quantum was designed to create technologies that solve concrete problems in cardiac surgery, cardiology and respiratory medicine. The primary objective of Quantum devices is to increase the safety of invasive procedures performed in worldwide cardiac surgical centers. First, we focus on highest volume procedures because supporting these will have the most significant impact on population health. We identify critical problems in medical procedures and therapy processes. We design the solution, organize specialist teams, and conduct the projects. Quantum uses scientific methodology to analyze and monitor the global market, population status, public health dynamics, progress in medicines, therapy guidelines, … Type: | 0 | 0 | 0 | 8 |
 | Leman Biotech Leman Biotech, a spin-off company of EPFL, aims at developing and commercializing new metabolic cancer immunotherapies Leman Biotech Co., Ltd. is a spin-off of EPFL co-founded by Prof. Li Tang (Head of Laboratory of Biomaterials for Immunoengineering). Leman Biotech aims at developing and commercializing new metabolic cancer immunotherapies. Recently, the start-up company closed a US$11 million angel financing round. The money raised will enable it to accelerate the preclinical studies of biomolecule and cell based therapies and prepare for entering clinical trials. The headquarter of the company is now in Shenzhen, a highly vibrant city with the highest number of … Type: | 0 | 0 | 0 | 2 |
 | RECORNEA Securing your vision Recornea is a clinical stage medtech ophthalmic company developing therapeutic solutions for treating diseases of the cornea, such as keratoconus, glaucoma and corneal transplants. Type: | 1 | 0 | 1 | 6 |
 | Ethris Ethris is paving a new path from genes to therapeutic proteins using its proprietary messenger RNA technology platform. Ethris is paving a new path from genes to therapeutic proteins using our proprietary messenger RNA technology. Developed in-house, our integrated platform enables the discovery, design and development of transcript therapies that restore missing functions in patients’ cells and tissues. We will advance transcript therapies to transform the treatment of disease independently and with our partners. Biotechnology, mRNA, LNPs, Vaccines, Therapeutics, Formulation, and Manufacturing Type: | 0 | 0 | 0 | 57 |
 | Calico Biosystems Predicting life-changing drugs for patients with cancer Calico Biosystems is on a mission to help pharma companies create effective, affordable drugs faster to counter cancer multi-omics assay, computational modeling, drug efficacy prediction, combination therapy, and Cell and virus-based therapeutics' efficacy Type: | 1 | 1 | 0 | 1 |
 | Incanthera plc A UK-based, dermatology and oncology therapeutics company focusing on discovery and development of targeted solutions. Type: | 0 | 0 | 0 | 1 |
 | PartitionBio Ltd Exploiting a proprietary tech platform to develop biomolecular tools for therapeutic & synthetic biology applications PartitionBio Exploiting a novel proprietary technology platform to develop biomolecular tools for the use in therapeutic and synthetic biology applications. contact@partitionbio.co.uk Type: | 0 | 0 | 0 | 13 |
 | NXI Therapeutics AG Creating Tomorrow's Immunotherapies NXI therapeutics focuses on the research and development of a new generation of selective immunosuppressive drugs for autoimmune diseases and transplantations - with objectives of high efficacy, good safety without adverse effects as seen with conventional immunosuppressants. Type: | 0 | 0 | 0 | 5 |
 | SERDA therapeutics Fast and effective therapeutic debridement of burn injuries and chronic ulcers. SERDA Therapeutics is a joint venture between Smith & Nephew and NLC, focused on developing innovative wound care solutions. The company is dedicated to bringing to market a proprietary, best-in-class, fast-acting therapeutic product for burn injuries and chronic ulcers. SERDA has completed a Phase 1 Safety and Tolerability study in July 2024. This study was a blinded, randomized study that examined the immediate and 21-day cumulative irritation potential of ascending enzyme concentrations in SN514 hydrogel. The results confirm best-in-class potential for SN514 as the protection of “periwound” skin is … Type: | 0 | 0 | 0 | 1 |
 | UPSIDE Foods At UPSIDE Foods (formerly known as Memphis Meats), we're making your favorite food a force for good. Meat made from cells. We’re building the future you’re hungry for. *all meat shown is UPSIDE meat https://linktr.ee/upsidefoods Cultivated meat is new to many of us, and here at UPSIDE, we encourage education, learning, and fact-based debate. We ask that, in accordance with our values, you keep the conversation respectful to each other and to us. Thanks! cell culture, cultured meat, food science, food tech, meat, food, research and development, biology, process development, cell-based meat, and cultured meat Type: | 16 | 6 | 4 | 254 |
 | Balt We are Balt. Physician-inspired innovations. Patient-focused solutions. For more than 45 years, Balt has been leading the way – collaborating with physicians and institutions to develop elegant neurovascular solutions. As the premier global neurovascular platform, always seeking to expand beyond boundaries, we are now bringing our innovation to the peripheral vascular space. We introduced the first neurovascular intervention device in 1977. Now, we offer the world’s broadest portfolio of medical devices for ischemic and hemorrhagic stroke, as well as devices for peripheral embolization. In 2015, we embarked on an ambitious journey and more than quintupled our revenue and workforce, and … Type: | 3 | 3 | 1 | 453 |
 | Laboratoire Bailly-Creat Bailly-Creat is a French pharmaceutical company, specialized in the manufacture and production of medicines. Heir to the know-how and expertise of the two major laboratories at the origin of its creation, the Bailly Creat laboratory is one of the oldest laboratories in France. Known for its know-how in the shaping of dry forms, specialist in pharmaceutical and parapharmaceutical production, Bailly-Creat produces and distributes its generic products in more than thirty countries. Type: | 1 | 0 | 1 | 69 |
 | ETR Improving health and well-being for youth and communities by championing science. ETR envisions a world where all people have the information, skills, and opportunities to achieve their best health. We are driven by our mission to improve health and well-being for youth and communities by championing science. ETR embraces the purposeful inclusion of all people as a means to honor and respect difference, and to elevate the strengths brought by diversity of experience, perspective, and expertise. Our multidisciplinary staff of health educators, program developers, trainers, curriculum specialists, writers, editors, graphic artists, librarians, publication and distribution experts, technologists and social scientists … Type: | 5 | 0 | 4 | 400 |
 | Auberle Auberle helps build strong individuals, families and communities. Auberle is a nationally recognized human services agency serving 4,000 children and families each year in 26 program areas in Southwestern Pennsylvania. Auberle was recognized by the Alliance for Children and Families as Agency of the Year in the country, primarily for our delivery of consistently high positive outcomes in programs across the agency; and for successfully launching 23 major initiatives last year that significantly improved services for the children and families we serve. The award and the accomplishments behind it demonstrate that leadership, pride and a focus on excellence are infused … Type: | 2 | 1 | 1 | 171 |
 | BridgingApps Bridging the gap between technology and people with disabilities. BridgingApps is a program of Easter Seals Greater Houston that provides access to educational and therapeutic tools—anywhere, anytime—allowing parents, teachers, and therapists to effectively use mobile devices and apps to target and improve individual skill development to help children and adults with disabilities reach their highest levels of physical and cognitive development. Type: | 3 | 0 | 2 | 7 |
 | H&T Presspart Impacting Tomorrow. Together. What We Do H&T Presspart is a world leader and specialist in manufacturing drug delivery devices and pharmaceutical components. With 50 years experience in partnering with the world’s leading pharma companies we have developed a strong reputation for precision and reliability – critically important when patients’ quality of life depends on our products. Our extensive skills and experience cover drug delivery device development and industrialisation and every aspect of high-volume precision deep-drawn manufacturing, injection moulding and high-speed assembly in ISO 7 and ISO 8 cleanrooms. As the Pharmaceutical industry continues to evolve, so do we. We focus … Type: | 2 | 0 | 0 | 305 |
 | Arzeda The Protein Design Company (TM) - new proteins and biochemistry for the production of valuable sustainable molecules Arzeda, The Protein Design CompanyTM, is a synthetic biology company that creates novel proteins, enzymes and specialty chemical products that compete on performance, cost and sustainability. Partnering with Fortune 500 companies, Arzeda has developed a portfolio of enzymes and specialty chemicals for polymers, pharmaceuticals, industrial chemicals and other advanced applications. More information at www.arzeda.com. Synthetic Biology, Bio-based Chemicals, and Protein Design Type: | 7 | 2 | 7 | 70 |
 | Nourishing the Future of Food and Beverages at IFF What’s the future of food and beverages? Follow us. We define the industry landscape by nourishing people, products and our planet. Every day, through our IFF PRODUCT DESIGNTM approach, we leverage our proprietary technologies; industry-leading portfolio of modulators, flavorings, texturants, inclusions, cultures, protein solutions and health ingredients; and unmatched innovation capabilities to reimagine tomorrow, today. Relentlessly dedicated and endlessly curious, our international collective thinkers co-creates with customers to pioneer the next generation of food and beverages. The result? Unforgettable taste experiences that delight consumers across the globe. Visit us at http://www.iff.com Carrageenan, Food Enzymes, Cellulose Gum, Guar, Locust Bean Gum, … Type: | 0 | 0 | 0 | 128 |
 | Contraline Contraline is a venture-backed, clinical-stage biotechnology company at the forefront of male contraception. medical device, biotechnology, urology, contraception, womenshealth, reproductivehealth, and menshealth Type: | 2 | 1 | 1 | 25 |
 | Akron Bio Powering the future of medicine Since 2006, Akron’s mission is to provide GMP-compliant materials and services that enable innovators to develop and commercialize advanced therapies. Along with its line of GMP quality cytokines, growth factors, blood-derived products, and custom media, Akron specializes in manufacturing custom plasmids and endonucleases to support viral vector and gene editing technologies. Akron’s newly opened 110,000 sq. ft. manufacturing facility operates in line with FDA 21 CFR Part 11 and Eudralex Vol 4 Annex 11 standards. Akron provides advanced therapy developers the scale, compliance, flexibility, and regulatory support to develop novel technologies from pre-clinical through to … Type: | 1 | 0 | 0 | 118 |
 | MTInov [Automatic translation follows] Scale-up platform for the production of innovative therapy drugs based on human cells or tissues. The Biotherapy-Bioproduction integrator MTInov was born in 2020 from the association of the Cellular Therapy Unit and Tissue Bank of the CHRU of Nancy and the Bioprocesses Biomolecules research axis of the Reactions and Process Engineering Laboratory (CNRS, UL). This platform for the study, optimization, and scaling up of the production of cell-based biomedicines has expertise in cell culture in stirred bioreactors (online monitoring, intensification, modeling and design of bioreactors), as well as in the transfer to clinical grade in compliance with … Type: | 6 | 2 | 0 | 2 |
 | ZMF RESOURCES Consulting services in Clinical Research and in Informatics Your Project, Our Mission! ZMF RESOURCES is a consulting company with offices in France. We provide tailor-made, high quality services - in Clinical Research (Regulatory, clinical operations, project management, GCP audit, QMS...) - and in Informatics (Web & Cloud Applications development and maintenance like ePRO, eCRF, IP compliance, website). We do operate internationally. CEO / founder: Zoé Moksi We are : - Passionate about our work and client satisfaction - Obsessed by quality, excellence, transparency and effectiveness - Collaborative and creative - Intensely curious and open minded - Agile and proactive - … Type: | 21 | 1 | 21 | 3 |
 | BS MEDICAL TECH INDUSTRY BS MEDICAL TECH INDUSTRY is a medical devices company based out of 2 RUE DE L'AVENIR, Niederroedern, Grandest, France. dispositif médical, Innovation, R&D, Urologie, Nutrition entérale, and Contract manufacturing Type: | 1 | 1 | 0 | 7 |
 | Bioharmony Therapeutics At Bioharmony Therapeutics, we are developing nontraditional antimicrobial therapeutics by exploiting millions of years of phage-bacteria evolution. Our focus is on targeting infectious diseases caused by multidrug-resistant (MDR) Gram-negative bacteria. Our primary therapeutic indication is for Acinetobacter baumannii skin and wound infections. Type: | 2 | 0 | 2 | 1 |
 | GraphWear Technologies Inc. #notblood GraphWear is a San Francisco based technology company that diagnoses and monitors chronic diseases continuously without any blood or urine. GraphWear's needle free continuous glucose monitoring system is currently being tested in the clinic for diabetes management. Nanotechnology, Non-invasive healthcare monitoring, Preventive healthcare, medical device, Wearable diagnostics, and continuous monitoring Type: | 3 | 1 | 1 | 20 |
 | Cleancard Combining synthetic biology and artificial intelligence to make cancer detection as easy as a pregnancy test. Cleancard is bringing lab-grade diagnostics into the comfort of your home. Our novel method enables robust diagnostics and biomarker tracking from the urine in just 30 minutes. Our rapid at-home screens can identify prostate, bladder and ovarian cancers. We are constantly expanding the number of conditions we can detect from a single sample using our platform technology. Type: | 0 | 0 | 0 | 7 |
 | Volumina Medical Addressing the problem of natural repair of soft tissues with injectable 3D scaffolds Volumina Medical is a multi-award-winning start-up active in the field of medical devices supported by a solid network of investors. The company develops breakthrough innovations for plastic and reconstructive surgery. The first product is an implantable polymeric biomaterial and targets the regeneration of soft tissue of the human body which are damaged after tumor excision, genetic malformation or trauma. Implants, Biomaterial, and Regenerative Medicine Type: | 2 | 1 | 1 | 12 |
 | Suvoda IRT, eConsent, and eCOA solutions to help you wisely guide novel science through complex clinical trials Suvoda is a global clinical trial technology company that provides IRT, eConsent and eCOA software and services for complex, life-sustaining studies in therapeutic areas like oncology, central nervous system, and rare disease. Clinical trial management, Interactive response technology, Subject randomization, Trial supply management, IWRS, IRT, Interactive Web Response System, Clinical Supplies, Patient Logistics, and Clinical Supply Logistics Type: | 10 | 1 | 9 | 958 |
 | Ryvu Therapeutics Developing novel treatments at the forefront of oncology Ryvu Therapeutics is a clinical-stage drug discovery and development company focused on novel small molecule therapies that address emerging targets in oncology. Internally discovered pipeline candidates make use of diverse therapeutic mechanisms driven by emerging knowledge of cancer biology, including small molecules directed at kinase, synthetic lethality, and immuno-oncology targets. Ryvu’s most advanced programs are RVU120 - a selective CDK8/CDK19 kinase inhibitor with potential for the treatment of hematological malignancies and solid tumors currently in Phase I clinical development for the treatment of acute myeloid leukemia and myelodysplastic syndrome, and Phase I/II … Type: | 8 | 0 | 8 | 286 |
 | Serna Bio Mapping the druggable transcriptome An estimated 85% of the ~3 billion base pairs in the human genome is transcribed into RNA, but only ~1.5% of these code for proteins. While the chemical properties of protein binders are increasingly understood and interrogated, the field of RNA-targeted drugs is relatively new and the properties of small molecules that drive specific and selective targeting of RNA, and associated assays, are yet to be developed. At Serna Bio [previously Ladder Therapeutics] we are using an AI enabled, data-first approach to write the rules that define RNA-small molecule interactions. Our Discovery Platform powers our first-in-class … Type: | 0 | 0 | 0 | 14 |
 | Foghorn Therapeutics Inc. Foghorn Therapeutics is pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention. Our proprietary Gene Traffic Control® platform gives us an integrated, mechanistic understanding of how the various components of the chromatin regulatory system interact, allowing us to identify, validate and potentially drug targets within the system. Type: | 3 | 2 | 4 | 126 |
 | Sio Gene Therapies Pushing the boundaries of gene therapy to develop treatments for debilitating neurodegenerative diseases. Sio Gene Therapies combines cutting-edge science with bold imagination to develop genetic medicines that aim to radically improve the lives of patients. Our current pipeline of clinical-stage candidates includes the first potentially curative AAV-based gene therapies for GM1 gangliosidosis and Tay-Sachs/Sandhoff diseases, which are rare and uniformly fatal pediatric conditions caused by single gene deficiencies. We are also expanding the reach of gene therapy to highly prevalent conditions such as Parkinson’s disease, which affects millions of patients globally. Led by an experienced team of gene therapy development … Type: | 2 | 1 | 1 | 29 |
 | UE LifeSciences Making the hope of early detection, a reality. Meet the team behind iBreastExam and cervAIcal! UE LifeSciences is a fast-growing, multi-national med-tech company bringing the promise of early detection of cancer to women globally. Our innovations have reached more than 250,000 women in 12 countries. We've grown revenue five-fold in the past three years with distribution in 10 countries and counting. And we've raised over $6 million in grants, international awards and equity capital! Our work is featured on platforms such as TED Talks and notable publications such as The New York Times, BBC World News, Forbes and others. Medical … Type: | 10 | 1 | 8 | 63 |
 |  OvaScience OvaScience, Inc. (NASDAQ:OVAS) is a company focused on the discovery and development of new treatment options for women and families struggling with infertility. Each OvaScience treatment is based on the Company’s proprietary technology platform that leverages the breakthrough discovery of EggPC cells – immature egg cells found within the outer ovarian cortex. OvaScience is developing OvaPrime, a potential fertility treatment that could help restore a woman’s egg production, and OvaTure, a potential fertility treatment that eliminates the need for hormone stimulation. OvaScience’s AUGMENT treatment, designed to improve fertilization and pregnancy rates, is available in Japan under an exclusive license to … Type: | 6 | 0 | 1 | 8 |
 | SimpleTherapy Personalized, clinically-based virtual and in-person solutions for total well-being. SimpleTherapy provides physical, MSK, and behavioral health services that combine digital and technology-guided treatment with a national network of in-person and telehealth providers. At our core is a commitment to providing inclusive, holistic care that is simple, accessible, and personalized. Our clinically backed, innovative solutions support the overall health of your workforce and reduce costs for all parties. Our clients include employers of all sizes, major health plans, and Fortune 50 organizations. SimpleTherapy, where improved health meets simplicity. Notable Media Coverage: - The New York Times: http://nyti.ms/1ivhBZC - The Huffington Post: … Type: | 1 | 0 | 1 | 31 |
 | InquisitHealth is now Pyx Health Delivering better health 1-1 via an empathy-first Peer workforce Health plans, health systems, and employers leverage our Peer workforce (tech-enabled remote workforce of community health workers) to engage struggling patients (with empathy!) and help them address SDoH barriers, activate healthy behaviors and improve clinical outcomes. peer support, peer mentoring, community health workers, diabetes, asthma, prediabetes, sickle cell, hypertension, digital health, and coaching Type: | 1 | 1 | 0 | 37 |
 | Synthorx Inc Synthorx, Inc. is a biotechnology company focused on prolonging and improving the lives of people with cancer and autoimmune disorders. Synthorx’s proprietary, first-of-its-kind Expanded Genetic Alphabet platform technology expands the genetic code by adding a new DNA base pair and is designed to create optimized biologics, referred to as Synthorins. A Synthorin is a protein optimized through incorporation of novel amino acids encoded by the new DNA base pair that enables site-specific modifications, which enhance the pharmacological properties of these therapeutics. The company’s lead product candidate, THOR-707, a variant of IL-2, is in development in multiple tumor types as a … Type: | 2 | 2 | 0 | 9 |
 | RxGenomix Making personalized healthcare possible for individuals, healthcare providers, benefit administrators and employers. Pharmacogenomics (PGx) is the next frontier in medication therapy management and RxGenomix was created specifically to help put it to work for everyone. RxGenomix helps healthcare providers understand the genetic-driven mechanisms behind the response to medications and navigate the implementation process of a new healthcare tool. By applying PGx testing, they can look at very specific pieces of their patients’ DNA to know, for many of the most common and critical medications, precisely which might be best for that individual, and at what dosage. Empowering healthcare providers with … Type: | 2 | 1 | 1 | 11 |
 | altizem [Automatic translation follows] I like it 😊 🔹 We are an operational consulting company specializing in the Life Sciences sector (pharmaceuticals, agri-food, medical devices, cosmetics and fine chemicals) of the MoOngy Group. We support our clients (Sanofi, Merck, Nestlé, LVMH, etc.) throughout the life cycle of a product, by mobilizing our consultant engineers and pharmacists. 🚀 Altizem represents an annual growth of +35%, a presence throughout France and strong values built around people. 🏆 We are ChooseMyCompany HappyAtWork and ImpactIndex 2022 certified. MoOngy is Ecovadis Gold accredited 🏆 🔥 Passion, Proximity, Performance & Commitment are the values that each Altizen … Type: | 52 | 0 | 52 | 140 |
 | ALBHADES [Automatic translation follows] Analytical Solutions for Health Products 💊💉 Expert in microbiology and physical chemistry, Albhades has been supporting the health product industries (pharmaceuticals, medical devices, cosmetics), the chemical and food industries since 2001. Its analytical capabilities combined with its consulting service offer a global solution to the needs of method development and validation, process validation and quality control of raw materials, finished products and packaging. Its multiple combination of expertise positions Albhades on a complete analytical offer including mineral chemistry, organic chemistry, NMR analysis, microbiology, cell biology, mechanical testing, stability studies and toxicology. Its strength lies in the personalized … Type: | 7 | 1 | 4 | 76 |
 | Benhur [Automatic translation follows] "The best ally for your company" We help you through digital marketing to reach another level! Type: | 4 | 2 | 2 | 39 |
 | Suomen Punainen Risti, Veripalvelu [Automatic translation follows] The Blood Service of the Finnish Red Cross produces safe and effective blood products and laboratory services for hospitals needed in the treatment of patients. We take care of collecting blood from voluntary blood donors in accordance with the needs of patient care. We also offer hospitals services that support stem cell and organ transplants. The blood service is a non-profit organization. Our annual budget is approximately 60 million. EUR and we employ about 500 people. We are part of a unique helping chain with donors and healthcare staff. blood products, laboratory services, stem cell and tissue … Type: | 1 | 1 | 0 | 202 |
 | POWERGYM Sport Nutrition [Automatic translation follows] Experts in Premium Quality Supplementation and Sports Nutrition, with more than 30 years of experience. Specialists, since 1991 being experts in premium quality supplements and sports nutrition. We are the only manufacturers nationwide, who design our products under high pharmaceutical quality standards, proof of this being the certifications obtained by the facilities where we develop and produce our entire range of supplementation and sports nutrition. Through scientific research our formulations exceed the expectations of our consumers. We develop Premium supplements for different objectives, such as: + Endurance + Fitness + Performance + Recovery POWERGYM: The Nutrition Science … Type: | 0 | 0 | 0 | 13 |
 | FARMALIDER Driving Innovation in Health Farmalider, S.A. is a private pharmaceutical company established in 1986 in Madrid, Spain. We specialize in research, development ,license and supply pharmaceutical product for areas as generics, prescription, OTC, consumer health care, value-added, Food Supplements. In addition, we identify new molecules for new chemical entity developments. Our products are currently approved by regulatory agencies in over 25 countries worldwide and marketed through strategic partners in each territory We have registered nearly 26 patents and continue to proactively seek projects where we can protect our innovations and technology. We have strong knowledge in several therapeutic fields including … Type: | 3 | 0 | 3 | 92 |
 | Liminal BioSciences Liminal BioSciences is a development-stage biopharmaceutical company focused on the discovery and development of novel distinctive small molecule therapeutics that modulate G protein-coupled receptor (GPCR) pathways. The company is developing new proprietary small molecule therapeutic candidates with the intention of developing best-in-class therapeutics for the treatment of unmet metabolic, inflammatory and fibrotic diseases, using its integrated drug discovery platform, expertise in medicinal chemistry and deep understanding of GPCR biology. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. See our social media community guidelines at https://liminalbiosciences.com/social-media-community-guidelines/ Type: | 1 | 0 | 1 | 29 |
 | Kuur Therapeutics Kuur is committed to transforming the lives of patients with cancer and is leading the development of off-the-shelf engineered CAR-NKT cell therapies. Our approach combines the highly differentiated, natural biology of a specific subset of T cells, called natural killer T cells (NKT cells) and innovative chimeric antigen receptor (CAR) construct engineering. In combination, this delivers a very compelling and unique platform, that we believe has the potential to produce many future therapies targeting both hematological and solid tumors. Immunotherapy, Cancer, Oncology, T cells, TCR, CAR, CAR-NKT, clinical trial, NKT Cells, celltherapy, and lifesciences Type: | 2 | 2 | 0 | 91 |
 | Eurotec Dental SAS Superior Care Solutions Eurotec Dental SAS is a medical devices company based in France. Exclusive Importer and distributor of A-dec USA Product portfolio on the French Market Type: | 1 | 1 | 0 | 9 |
 | FRANCE NEIR [Automatic translation follows] France Neir, manufacturer and distributor of medical equipment since 1946. France Neir is a company specializing in the design, manufacture and distribution of innovative products in the field of occupational health and medicine. With over 60 years of experience, we offer a range of over 10,000 references in care products, dressings, first aid kits, first aid, OHS training, workstation ergonomics, as well as equipment for preventing risks at work and diagnostics for the occupational physician. Customer service: France Neir cultivates its difference by having a team of 11 technical sales representatives on French territory in order to … Type: | 2 | 1 | 1 | 33 |
 | Acime Frame Mindful Design ACIME FRAME has been designing and manufacturing mobile medical equipment for patient transport and care since 1990. Our comprehensive range of products includes stretchers, transfer chairs, treatment chairs, ambulatory surgery chairs, examination couches, and screens. We strive to provide patients and caregivers with the most user-friendly medical devices: comfort, durability, innovation, design, and adaptability are at the core of our mission to improve the recovery process. We work with healthcare providers to identify and analyse their needs and thus provide them with the best solutions to make their lives easier. ambulatory care, patient transfer, emergencies, dialysis, day hospital, … Type: | 4 | 3 | 2 | 81 |
 | SCHILLER France [Automatic translation follows] The Art of Diagnosis The Art of Saving Lives SCHILLER FRANCE is the leader in France in the development, production and distribution of medical devices for cardiopulmonary diagnosis, patient monitoring and emergency medicine. With its Research & Development and Production center located in Alsace, Schiller offers innovations that perfectly meet the French market. Discover our e-shop: https://www.mediprostore.com/ Defibrillation, Echocardiography, Spirometry, First Aid Training, and Cardiology Monitoring Type: | 1 | 1 | 0 | 130 |
 | PRATICIMA [Automatic translation follows] Designer of solutions for healthcare facilities Praticima was born from the merger of three brands: Praticdose, Cima and Adhésia, respective leaders in their markets. Designer of medical equipment for healthcare facilities, Praticima is present in France and internationally. With two sites: in Reyrieux and Avranches, Praticima offers the guarantee of proximity to the customer and the image of French know-how. The products are designed by the design office and manufactured in France. Praticima does not simply distribute products. The brand sets up solutions for the establishments it supports: listening, advice, anticipation and customization! Praticima's teams are able … Type: | 1 | 1 | 1 | 83 |
 | Villard Medical Designer & Manufacturer of Hospital Furniture since 1947. Villard Medical - Designer & Manufacturer of Hospital Furniture. Founded in 1947 in Le Mans, company Villard Medical became one of the French leaders in design, manufacturing and sales of Medical Equipment & Furniture for French and International Healthcare Centers (hospitals, private clinics, retirement homes, ...). Our Research Department helps us to be attuned to our clients' needs and to be considered as "A creator of hospital solutions". ► A REFERENCE IN THE HOSPITAL ENVIRONMENT Villard Medical develop reliable and high-performance equipment which became a reference for hospitals, clinics and retirement houses … Type: | 4 | 2 | 4 | 32 |
 | Creapharm, a Myonex company Whether your health product is still in research, is entering a clinical trial, or is ready to be marketed, Creapharm, a Myonex company, is a total global partner committed to assisting and supporting a wide range of projects with supply and services from clinical to commercial. With ten locations in the US, Germany, UK & France, we partner with pharmaceutical and biotechnology companies, contract research organizations (CROs), hospitals, and sites seeking a flexible, comprehensive solution for their project needs. Learn more at www.creapharm.com Clinical Services include: Primary and secondary packaging and labeling Drug sourcing CTRx TM Ancillaries Compounding Pharmaceutical support, … Type: | 13 | 2 | 10 | 144 |
 | Portal Instruments Connected, Needle-Free Drug Delivery Portal Instruments is a Series B funded medical device company focused on advanced drug delivery and backed by strategic and venture investors. We are developing and commercializing a highly innovative needle-free drug delivery platform technology to transform the administration of medicines and improve the patient experience for those with chronic disease who inject themselves. Portal’s needle-free delivery technology is derived from research at MIT and enables the administration of high viscosity biologic drugs with less discomfort and without the anxiety of handling needles. Using precise pressure technology, the injection is administered through the skin via a … Type: | 1 | 1 | 1 | 31 |
 | REGENXBIO Seeking to improve lives through the curative potential of gene therapy. REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. Since its founding in 2009, REGENXBIO has pioneered the development of AAV Therapeutics, an innovative class of gene therapy medicines. REGENXBIO is advancing a pipeline of AAV Therapeutics for retinal and rare diseases, including ABBV-RGX-314 for the treatment of wet AMD and diabetic retinopathy, being developed in collaboration with AbbVie, RGX-202 for the treatment of Duchenne and RGX-121 for the treatment of MPS II. Thousands of patients have been treated with … Type: | 1 | 1 | 0 | 363 |
 | Sage Therapeutics Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. We are pursuing new pathways with the goal of improving brain health and change how brain disorders are thought about and treated. Our mission is to pioneer solutions with the potential to deliver life-changing brain health medicines, so every person can thrive. Welcome To The Workplace With A Difference At Sage, we believe that life is more … Type: | 8 | 2 | 4 | 621 |
 | Aimmune Therapeutics POWER OVER FOOD ALLERGIES Aimmune Therapeutics, Inc., a Nestlé Health Science Company, is a biopharmaceutical company developing and commercializing treatments for potentially life-threatening food allergies. With a mission to improve the lives of people with food allergies, Aimmune is developing and commercializing oral treatments for potentially life-threatening food allergies. The Company’s Characterized Oral Desensitization ImmunoTherapy (CODITTM) approach is intended to provide meaningful levels of protection against allergic reactions resulting from accidental exposure to food allergens by desensitizing patients with defined, precise amounts of key allergens. Aimmune has one FDA-approved medicine for peanut allergy and other investigational therapies in development to … Type: | 1 | 1 | 0 | 118 |
 | Prapela Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Prapela is a breakthrough noninvasive stimulation therapy that naturally improves breathing and oxygenation in newborns. Based on a field of science called Stochastic Resonance, our precise and gentle stimulation improves breathing rhythm and lung function in newborns. Since 2017, we've received over $8M in awards and grants funding the clinical evaluation of our therapy to improve the treatment of opioid-exposed newborns and preterm infants with apnea of prematurity. Next, we aim to improve the treatment of preterm intermittent hypoxemia and bronchopulmonary dysplasia. For more information, … Type: | 1 | 0 | 1 | 4 |
 | Recursion Decoding Biology to Radically Improve Lives We are a clinical-stage TechBio company decoding biology by integrating technological innovations across biology, chemistry, automation, data science and engineering to industrialize drug discovery. We are leveraging new technology to create virtuous cycles of learning around datasets to build the next-generation biopharmaceutical company. It’s complex biology, decoded. While we are united in a common mission, Decoding Biology to Radically Improve Lives, our greatest strength lies in our differences: expertise, gender, race, disciplines, experience, and perspectives. Deliberately building and cultivating this culture is critical to achieving our audacious goals. We are proudly headquartered in Salt … Type: | 24 | 4 | 20 | 602 |
 | Laser Biotech International Superpulsed therapeutic lasers: Lumix 2 Series, Superpulsed + CW therapeutic lasers: Lumix 3 Series, Superpulsed + CW therapeutic lasers: Lumix 4 Series, Lumix Lasers, drug free pain relief, pain relief, laser therapy, alternative medicine, Chiropractic, dentistry, physical therapy, pain management, superpulsed lasers, therapeutic lasers, sports medicine, medical devices, and technology Type: | 0 | 0 | 0 | 3 |
 | Verastem Oncology Verastem Oncology (Nasdaq: VSTM) (Verastem, Inc.) is a late-stage development biopharmaceutical company committed to the development and commercialization of new medicines to improve the lives of patients diagnosed with cancer. Our pipeline is focused on novel small molecule drugs that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, including RAF/MEK inhibition and FAK inhibition. Pursuing unexplored pathways demands that we’re purposeful in everything we do. And it’s an endeavor that’s only possible with an experienced team of employees and partners dedicated to a singular purpose: changing and improving the way cancer is treated by … Type: | 3 | 1 | 2 | 104 |
 | Lygos Better materials for better products Lygos is a pioneering sustainable specialty chemicals company, leading the world’s transition toward better, cleaner, and more sustainable products. We have built a proprietary and fully integrated platform of the most advanced technologies across synthetic biology, industrial chemistry, and application development to rapidly deliver market relevant solutions to some of the world’s biggest sustainability challenges. With a pipeline of high-performing, innovative solutions, Lygos is paving the way for generations of new sustainable solutions for our world. Synthetic Biology and Specialty Chemicals Type: | 1 | 0 | 1 | 87 |
 | Newel Health Beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions Newel Health represents a novel category of innovative companies whose mission is to develop and commercialize beautifully designed and clinically validated digital medicine and digital therapeutics (DTx) solutions in partnership with pharmaceutical and medical device companies and other health and wellness stakeholders. Built on a strong heritage in health innovation Newel Health leverages data and technology to future-proof healthcare, while putting human empathy and patients’ and HCPs’ actual needs at the center of all its products. Type: | 1 | 1 | 0 | 15 |
 | SynBiotic SE [Automatic translation follows] MAKING CANNABINOIDS ACCESSIBLE What our ancestors knew instinctively and through centuries-old traditions is now increasingly proven by scientific research: the active ingredients of the Cannabis sativa plant, the so-called cannabinoids, show many positive effects when used for medical purposes, such as for chronic pain and epilepsy. But ingredients of the Cannabis sativa plant are also increasingly being used in the field of cosmetics and dietary supplements. Synbiotic SE aims to map the entire value chain of the Cannabis sativa plant for the benefit of people: from basic research to the synthetic production of these substances to the … Type: | 0 | 0 | 0 | 4 |
 | Elixirgen Scientific Transform how you model human biology. Elixirgen Scientific is a global leader in regenerative medicine and biotechnology, headquartered in the Science + Technology Park at the Johns Hopkins Medical Campus in Baltimore, MD. Our mission is to advance science and medicine with fast, functional, and scalable induced pluripotent stem cell (iPSC) differentiation products and services. Our state-of-the-art, transcription-factor-based technology allows you to overcome the high cost and inefficiencies associated with lengthy cell differentiation periods. We empower research institutions, pharmaceutical organizations, and biomedical enterprises worldwide, even those with no previous iPSC experience, by increasing access to relevant cells for modeling human … Type: | 1 | 1 | 0 | 20 |
 | MyoKardia Driven by the heart We officially combined with Bristol Myers Squibb to further strengthen our scientific capabilities and treatments for cardiovascular patients. Visit www.bms.com to learn more about our work to produce the next generation of medicines for patients with serious cardiovascular disease. For more information on the acquisition, see our press release at: https://one.bms.com/40FsT7W Genetic Heart Disease, Cardiomyopathy, biotechnology, cardiovascular disease, heart failure, precision medicine, therapeutics, drug discovery, drug development, and R&D Type: | 1 | 0 | 1 | 42 |
 | Geltor Geltor is the biodesign company powering the products of the future with effective, sustainable, animal-free proteins Geltor is the biodesign company that audaciously imagines and deeply explores all the possibilities that the tree of life has to offer. With customer benefit at the fore of each step of the creative process, Geltor has created the largest selection of designer proteins that are crafted with unparalleled biocompatibility and functionality. These proteins are 100% animal- and GMO-free, globally scalable, and sustainably cultivated. Geltor’s products are the result of endless curiosity and ceaseless optimization, clinically demonstrated for high performance. Biotechnology, Protein, Cosmetics, Personal … Type: | 4 | 1 | 2 | 25 |
Startup